
CAMP4’s trek to speed drug discovery and treat disease through prediction
We’re proud to share some exciting news from the Polaris portfolio: CAMP4 Therapeutics has officially launched with a $30 Million Series A round to pursue its mission of finding a treatment option for every disease. The round was led by… Read More ›